Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Court extends ABC, VA contract

Executive Summary

U.S. Court of Federal Claims order allows AmerisourceBergen to continue serving as Department of Veterans Affairs prime vendor for 45 days beyond contract expiration. Feb. 11 consent order on ABC's protest of VA contract award to McKesson schedules hearing for March 11, stipulating a ruling will be handed down by March 25. ABC filed the complaint Jan. 21 (1"The Pink Sheet" Jan. 26, 2004, In Brief)...

You may also be interested in...



AmerisourceBergen challenges VA contract

AmerisourceBergen files complaint in U.S. Court of Federal Claims seeking that the Department of Veterans Affairs' pharmaceutical prime vendor contract with McKesson be overturned and awarded to ABC. The drug wholesaler has filed a motion to keep the complaint under seal. ABC recently declared McKesson's cost minus 5% contract with VA to be "irresponsible" (1"The Pink Sheet" Jan. 12, 2004, p. 31)...

European Parliament To Vote On MDR Delay As Council Rectifies Critical Mistake

The EU is pulling out all the stops to have the one-year delay to the MDR adopted before it is too late, and a crucial vote will take place on 16 April.

Coronavirus Update: FDA Fast-Tracks Blood Plasma Trials, Novavax Closes In On Vaccine Start

As US cases set to reach half a million, FDA gives green light to blood plasma trials to help meet urgent need for therapies.

UsernamePublicRestriction

Register

PS043334

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel